Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07820228) titled 'Survival Analysis of Early TNBC Women Treated With Dose Dense Sequential Adjuvant Chemotherapy' on Sept. 9.

Study Type: Observational

Primary Sponsor: Hellenic Cooperative Oncology Group

Condition: Triple Negative Breast Cancer

Recruitment Status: Not recruiting

Date of First Enrollment: December 10, 1996

Target Sample Size: 3648

Countries of Recruitment: Greece

To know more, visit https://clinicaltrials.gov/study/NCT07820228

Published by HT Digital Content Services with permission from Health Daily Digest....